Sox2 Acts in Thalamic Neurons to Control the Development of Retina-Thalamus-Cortex Connectivity
Sara Mercurio,
Linda Serra,
Alessia Motta,
Lorenzo Gesuita,
Luisa Sanchez-Arrones,
Francesca Inverardi,
Benedetta Foglio,
Cristiana Barone,
Polynikis Kaimakis,
Ben Martynoga,
Sergio Ottolenghi,
Michèle Studer,
Francois Guillemot,
Carolina Frassoni,
Paola Bovolenta,
Silvia K. Nicolis
Affiliations
Sara Mercurio
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy
Linda Serra
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy; Université Côte d’Azur, CNRS, Inserm, iBV, Nice, France
Alessia Motta
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy
Lorenzo Gesuita
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy
Luisa Sanchez-Arrones
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid and CIBER de Enfermedades Raras (CIBERER), ISCIII Madrid, Madrid, Spain
Francesca Inverardi
Clinical and Experimental Epileptology Unit, Fondazione I.R.C.C.S. Istituto Neurologico “Carlo Besta”, c/o AMADEOLAB, via Amadeo 42, 20133 Milano, Italy
Benedetta Foglio
Clinical and Experimental Epileptology Unit, Fondazione I.R.C.C.S. Istituto Neurologico “Carlo Besta”, c/o AMADEOLAB, via Amadeo 42, 20133 Milano, Italy
Cristiana Barone
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy
Polynikis Kaimakis
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid and CIBER de Enfermedades Raras (CIBERER), ISCIII Madrid, Madrid, Spain
Ben Martynoga
The Francis Crick Institute, Midland Road, London NW 1AT, UK
Sergio Ottolenghi
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy
Michèle Studer
Université Côte d’Azur, CNRS, Inserm, iBV, Nice, France
Francois Guillemot
The Francis Crick Institute, Midland Road, London NW 1AT, UK
Carolina Frassoni
Clinical and Experimental Epileptology Unit, Fondazione I.R.C.C.S. Istituto Neurologico “Carlo Besta”, c/o AMADEOLAB, via Amadeo 42, 20133 Milano, Italy
Paola Bovolenta
Centro de Biología Molecular Severo Ochoa, Consejo Superior de Investigaciones Científicas - Universidad Autónoma de Madrid and CIBER de Enfermedades Raras (CIBERER), ISCIII Madrid, Madrid, Spain
Silvia K. Nicolis
Department of Biotechnology and Biosciences, University of Milano-Bicocca, piazza della Scienza 2, 20126 Milano, Italy; Corresponding author
Summary: Visual system development involves the formation of neuronal projections connecting the retina to the thalamic dorso-lateral geniculate nucleus (dLGN) and the thalamus to the visual cerebral cortex. Patients carrying mutations in the SOX2 transcription factor gene present severe visual defects, thought to be linked to SOX2 functions in the retina. We show that Sox2 is strongly expressed in mouse postmitotic thalamic projection neurons. Cre-mediated deletion of Sox2 in these neurons causes reduction of the dLGN, abnormal distribution of retino-thalamic and thalamo-cortical projections, and secondary defects in cortical patterning. Reduced expression, in mutants, of Sox2 target genes encoding ephrin-A5 and the serotonin transport molecules SERT and vMAT2 (important for establishment of thalamic connectivity) likely provides a molecular contribution to these defects. These findings unveil thalamic SOX2 function as a novel regulator of visual system development and a plausible additional cause of brain-linked genetic blindness in humans. : Biological Sciences; Neuroscience; Developmental Neuroscience Subject Areas: Biological Sciences, Neuroscience, Developmental Neuroscience